Ordering
Available Variants50 mg
CHJ.96169-50mg
Price
€60.00
Available – Dispatch in 14 days
100 mg
CHJ.96169-100mg
Price
€107.20
Available – Dispatch in 14 days
500 mg
CHJ.96169-500mg
Price
€686.40
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
50 mg | CHJ.96169-50mg | €60.00 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHJ.96169-100mg | €107.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
500 mg | CHJ.96169-500mg | €686.40 |
powder, suitable for cell culture, BioXtra
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C47H73NO17 |
|---|---|
| CAS Number | 1397-89-3 |
| Molecular Weight | 924.08 |
| UNSPSC Code | 12352207 |
| eCl@ss | 34010400 |
| PubChem Substance ID | 24891468 |
| NACRES | NA.76 |
| Beilstein/REAXYS Number | 78342 |
| MDL number | MFCD00877763 |
Safety Information Handling visibility
| pictograms |
GHS08
 GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H372 |
| pcodes | P260 - P264 - P270 - P314 - P501 |
| Hazard Classifications | STOT RE 1 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | dust mask type N95 (US), Eyeshields, Gloves |
Technical Overview & Applications Use-case context
Amphotericin B solubilized, with a CAS number of 1397-89-3, is a polyene antifungal medication that is commonly used to treat various fungal infections. The solubilized form of this compound enhances its bioavailability, allowing for more effective treatment of systemic fungal infections. Amphotericin B works by binding to ergosterol in the fungal cell membrane, creating pores that disrupt cellular function and ultimately lead to cell death. This mechanism of action is effective against a wide range of fungal species, including Candida, Aspergillus, and Cryptococcus. The solubilized form of Amphotericin B is often used in clinical settings to treat severe fungal infections, particularly in immunocompromised patients, and is typically administered intravenously to ensure optimal distribution and efficacy. Its solubilization enhances the drugs therapeutic potential, making it a valuable treatment option for life-threatening fungal infections.
